Dr. Gilberto Lopes, MD

  • Miami, FL
  • Medical oncologist
NPI1912350596PAC ID6103108139
Medicare services, 2024
486
Medicare patients, 2024
102
Part D claims, 2024
822
Publications
206
Clinical trials
5
Practice address
1611 Nw 12th Ave, Miami, FL 33136
Practice phone
Call (305) 585-1111
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Jackson Memorial Hospital

Hospital · Miami, Florida

Find Dr. Lopes' professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Gilberto Lopes is a medical oncologist in Miami, Florida

Dr. Lopes practices at Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County.

Dr. Lopes' NPI, 1912350596, was assigned on July 19, 2016. Dr. Lopes graduated from Federal University of Rio Grande do Sul School of Medicine in 1997. Dr. Lopes holds Florida license ME85706.

NPI and contact details
Medicare PAC ID
6103108139
NPI enumeration date
July 19, 2016
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(305) 585-1111
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
55
Medical school graduation
1997

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Gilberto Lopes practices at Jackson Memorial Hospital in Miami, Florida

Dr. Lopes' primary practice is Jackson Memorial Hospital, at 1611 Nw 12th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 585-1111.

Source: Dmand AI Affiliation Data

Dr. Gilberto Lopes is affiliated with 2 sites of care and 1 medical group

Dr. Lopes' primary practice is Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County. Dr. Lopes is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Gilberto Lopes' practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lopes practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Jackson Memorial HospitalAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Lopes practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Miami-Dade County and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Gilberto Lopes is one of 477 medical oncologists in Florida

Medical oncology is Dr. Lopes' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Lopes is board certified in medical oncology by the American Board of Internal Medicine. Dr. Lopes is licensed in Florida.

Specialties and state licenses

  • Medical oncology, FloridaPrimaryLicense ME85706 · 2002 to 2027 · taxonomy 207RX0202X

Clinical focus

Dmand AI lists breast cancer, chronic leukemia, colorectal cancer, lung cancer and multiple myeloma among the conditions Dr. Lopes treats.

Medical oncologists near Dr. Lopes

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Gilberto Lopes billed Medicare for 486 services in 2024

CMS data shows 486 Medicare services from Dr. Lopes across 5 procedure codes in 2024, for 102 Medicare patients. Medicare paid $29,691 for them.

Medicare services, 2024486
Medicare patients102
Paid by Medicare$29,691
Procedure codes5

Dr. Lopes' Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2492024: 30522%
Other services
2023: 02024: 181

Where Dr. Lopes' Medicare services took place, 2024

  • In an office25452%
  • In a facility23248%

Dr. Lopes compared with the Florida median for medical oncologists, 2024

  • Dr. Lopes
  • Florida median
Medicare services
486vs 19,75598% below
Medicare patients
102vs 54181% below
Part D claims
543vs 5989% below

Medians across 462 medical oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Lopes' most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Lopes

Need commercial claims for Dr. Lopes?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lopes and other medical oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Gilberto Lopes treated 102 Medicare patients in 2024, average age 73

CMS counts 102 Medicare patients who saw Dr. Lopes in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have cancer, and 73% have high cholesterol. 51% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lopes' median patient age at 69, with 46% women.

Medicare patients, 2024102
Average age73
Average risk score2.40
Also on Medicaid51%

Dr. Lopes' Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Lopes' Medicare patients by sex, 2024

  • Women6261%
  • Men4039%

Chronic conditions among Dr. Lopes' Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol73%
  3. High blood pressure69%
  4. Arthritis40%
  5. Diabetes38%
  6. Anxiety32%
  7. COPD28%
  8. Mood disorders28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Lopes' patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women46%
  • Men54%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Gilberto Lopes wrote 822 Medicare Part D claims in 2024

In 2024, Dr. Lopes wrote 822 Medicare Part D claims for 82 patients. 75% of them were for generic drugs. CMS names the drug for 543 of them, across 29 drugs with 11 or more claims each, at $1,371,879 in total drug cost. In 2023, CMS named 404 claims across 24 drugs.

Part D claims, 2024822
Drugs named by CMS29
Total drug cost$1.4M
Part D patients82

Dr. Lopes' Part D claims by kind of drug, 2024

  • Generic619 claims75%
  • Brand-name203 claims25%

Dr. Lopes' most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Lopes' Part D claims, 2024

  • Opioids3%26 of 822 claims
  • Antibiotics7%59 of 822 claims
  • Antipsychotics, patients 65 and over2%13 of 822 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4042024: 54334%

Drugs named by CMS: 29 in 2024, 24 in 2023.

See all prescribing by Dr. Lopes

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Gilberto Lopes scored 88 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Lopes for performance year 2024, reported as part of a group. Dr. Lopes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lopes as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Lopes' MIPS scores, performance year 2024

  • 88of 100Final score
  • 78.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Lopes by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Gilberto Lopes has 206 publications on record

Dmand AI links 206 papers to Dr. Lopes, published from 2004 to 2025. 2019 was the busiest year, with 16. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Antineoplastic Combined Chemotherapy Protocols. Dr. Lopes has published most often in J Glob Oncol. Dr. Lopes' most frequent co-authors are Luis E. Raez, MD, Samuel A. Kareff, MD, MPH and Estelamari Rodriguez, MD.

Papers206
Years published2004 to 2025

Dr. Lopes' papers by year, 2016 to 2025

Topics Dr. Lopes writes about most

  • Lung Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Antineoplastic Combined Chemotherapy Protocols
  • Antineoplastic Agents
  • Breast Neoplasms
  • Medical Oncology
  • Antibodies, Monoclonal, Humanized
  • Cost-Benefit Analysis

Dr. Lopes' most frequent co-authors

Recent publications by Dr. Lopes

See all 206 publications and co-authors

See who Dr. Lopes researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lopes works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Gilberto Lopes has worked on 5 clinical trials

Dmand AI links Dr. Lopes to 5 clinical trials, 2 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Non-Small-Cell Lung and Dehydration.

Clinical trials with Dr. Lopes by phase

  1. 2Phase 1: 2 trials
  2. 1Phase 1/2: 1 trial
  3. NonePhase 2: no trials
  4. 1Phase 3: 1 trial
  5. NonePhase 4: no trials

Conditions in Dr. Lopes' trials

  • Breast Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Dehydration
  • Neoplasm Metastasis
  • Breast Diseases

Investigators on the most trials with Dr. Lopes

Recent clinical trials with Dr. Lopes

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Gilberto Lopes received $118,980 in industry payments from 2016 to 2025

CMS Open Payments shows 82 general payments to Dr. Lopes from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. AstraZeneca Pharmaceuticals LP paid the most, $40,381. It also lists 1 research payment totaling $394 in 2018.

General payments to Dr. Lopes by program year, 2016 to 2025

General payments to Dr. Lopes by kind, 2016 to 2025

$119Kin total
  • Consulting fees$63,78854%
  • Speaker and faculty fees$25,48021%
  • Travel and lodging$14,64512%
  • Honoraria$13,33011%
  • Food and beverage$1,7371%

Companies that paid Dr. Lopes the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Lopes

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Gilberto Lopes graduated from Federal University of Rio Grande do Sul School of Medicine

Dr. Lopes graduated from Federal University of Rio Grande do Sul School of Medicine in 1997.

  1. Medical schoolFederal University of Rio Grande do Sul School of Medicine
  2. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Gilberto Lopes accepts plans from 9 insurance carriers

Dr. Lopes is in network with 9 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.

  • Elevance
  • Aetna
  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • Molina
  • Aspirus Health Plan
  • Blue Cross and Blue Shield of Kansas City
  • CMS Medicare
  • +1 more carriersWith a free account

Plan types Dr. Lopes accepts, by number of carriers

  1. HMO5
  2. Medicare5
  3. POS5
  4. PPO5
  5. EPO3
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Gilberto Lopes's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Gilberto Lopes

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Gilberto Lopes' NPI number?

Dr. Gilberto Lopes' NPI number is 1912350596. It was assigned on July 19, 2016, and it is active in the NPI Registry.

What kind of doctor is Dr. Gilberto Lopes?

Dr. Gilberto Lopes is a medical oncologist in Miami, Florida. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Gilberto Lopes practice?

Dr. Lopes practices at 1611 Nw 12th Ave, Miami, FL 33136. Dr. Lopes' primary practice is Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County.

What is Dr. Gilberto Lopes' office phone number?

The practice phone on file for Dr. Lopes is (305) 585-1111.

What is Dr. Gilberto Lopes' medical license number?

Dr. Lopes holds Florida license ME85706.

Which hospitals is Dr. Gilberto Lopes affiliated with?

Dr. Lopes practices at Jackson Memorial Hospital in Miami, Florida. Dr. Lopes is also affiliated with Sylvester Comprehensive Cancer Center.

What medical group is Dr. Gilberto Lopes part of?

Dr. Lopes is linked to University of Miami Health System.

Does Dr. Gilberto Lopes accept Medicare?

Yes. CMS data shows Dr. Lopes billed Medicare for 486 services in 2024, and Dr. Lopes accepts Medicare assignment.

Does Dr. Gilberto Lopes offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Lopes as offering telehealth services.

What is Dr. Gilberto Lopes' MIPS score?

Dr. Lopes' MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Gilberto Lopes see?

CMS counts 102 Medicare patients who saw Dr. Lopes in 2024, with an average age of 73.

Is Dr. Gilberto Lopes board certified?

Yes. Dr. Lopes is board certified in medical oncology by the American Board of Internal Medicine.

What services does Dr. Gilberto Lopes bill to Medicare?

In 2024, Dr. Lopes' most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and office visit, established patient (99215).

Where did Dr. Gilberto Lopes go to medical school?

Dr. Lopes graduated from Federal University of Rio Grande do Sul School of Medicine in 1997.

What drugs does Dr. Gilberto Lopes prescribe most?

In 2024 Medicare Part D data, Dr. Lopes' most prescribed drugs by claims were Prednisone, Doxycycline Hyclate and Eliquis.

Has Dr. Gilberto Lopes received payments from drug or device companies?

CMS Open Payments shows $118,980 in general payments to Dr. Lopes from 18 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Gilberto Lopes been practicing?

Dr. Lopes graduated from medical school in 1997, 29 years ago.

Does Dr. Gilberto Lopes do research?

Dmand AI links 206 publications to Dr. Lopes, published from 2004 to 2025. Dr. Lopes has worked on 5 clinical trials.

Who does Dr. Gilberto Lopes publish with?

Dr. Lopes' most frequent co-authors are Luis E. Raez, MD (10 shared papers), Samuel A. Kareff, MD, MPH (8 shared papers) and Estelamari Rodriguez, MD (8 shared papers).

What insurance does Dr. Gilberto Lopes accept?

Dr. Lopes is in network with 9 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)